Responses
Drugs and Devices in COPD
P288 Copd patients with varying severity of airflow limitation achieve highest peak inspiratory flow rate via the breezhaler® inhaler compared to the ellipta® or the handihaler® dry powder inhalers
Compose a Response to This Article
Other responses
No responses have been published for this article.